UnitedHealth Group’s stock price declined by 27% in the days following the release of the company’s Q1 earnings results on April 17, which underperformed Wall Street expectations.
Strategist | strategy-catalyst
UHG stock plummets after MA data shows high utilization
Related Topics:
Payer StrategyRelevant Roles:
Chief Strategy Officers